Effects of an Epithelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Add-on in Stereotactic Radiosurgery for Brain Metastases Originating from Non-Small-Cell Lung Cancer
Hyun Jung Kim, Woo Sung Kim, Do Hoon Kwon, Young Hyun Cho, Chang-Min Choi
J Korean Neurosurg Soc. 2015;58(3):205-210.   Published online 2015 Sep 30     DOI: https://doi.org/10.3340/jkns.2015.58.3.205
Citations to this article as recorded by Crossref logo
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study
Vineeth Tatineni, Patrick J. O’Shea, Shreya Saxena, Atulya A. Khosla, Ahmad Ozair, Rupesh R. Kotecha, Xuefei Jia, Yasmeen Rauf, Erin S. Murphy, Samuel T. Chao, John H. Suh, David M. Peereboom, Manmeet S. Ahluwalia
Cancers.2023; 15(11): 3015.     CrossRef
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses
Ai Seon Kuan, Chi-Lu Chiang, Hsiu-Mei Wu, Huai-Che Yang, Ching-Jen Chen, Chung-Jung Lin, Wan-Yuo Guo, David Hung-Chi Pan, Wen-Yuh Chung, Cheng-Chia Lee
Journal of Neuro-Oncology.2023; 164(3): 729.     CrossRef
Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non–small cell lung cancer patients with brain metastases
Guan-Ying Chiou, Chi-Lu Chiang, Huai-Che Yang, Chia-I Shen, Hsiu-Mei Wu, Yu-Wei Chen, Ching-Jen Chen, Yung-Hung Luo, Yong-Sin Hu, Chung-Jung Lin, Wen-Yuh Chung, Cheng-Ying Shiau, Wan-Yuo Guo, David Hung-Chi Pan, Cheng-Chia Lee
Journal of Neurosurgery.2022; 137(2): 563.     CrossRef
Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review
Pierre-Yves Borius, Jean Régis, Alexandre Carpentier, Michel Kalamarides, Charles Ambroise Valery, Igor Latorzeff
Cancer and Metastasis Reviews.2021; 40(1): 341.     CrossRef
Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
Raees Tonse, Martin C. Tom, Minesh P. Mehta, Manmeet S. Ahluwalia, Rupesh Kotecha
Cancers.2021; 13(15): 3682.     CrossRef
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
Stephanie G. C. Kroeze, Corinna Fritz, Jana Schaule, Oliver Blanck, Klaus Henning Kahl, David Kaul, Shankar Siva, Sabine Gerum, An Claes, Nora Sundahl, Sonja Adebahr, Susanne Stera, Markus M. Schymalla, Nasrin Abbasi-Senger, Daniel Buergy, Michael Geier,
Cancers.2021; 13(19): 4780.     CrossRef
Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches
Raj Singh, Eric J. Lehrer, Stephen Ko, Jennifer Peterson, Yanyan Lou, Alyx B. Porter, Rupesh Kotecha, Paul D. Brown, Nicholas G. Zaorsky, Daniel M. Trifiletti
Radiotherapy and Oncology.2020; 144: 165.     CrossRef
Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
Muhammad Khan, Sumbal Arooj, Rong Li, Yunhong Tian, Jian Zhang, Jie Lin, Yingying Liang, Anan Xu, Ronghui Zheng, Mengzhong Liu, Yawei Yuan
Frontiers in Oncology.2020;[Epub]     CrossRef
The Effect of Epidermal Growth Factor Receptor Mutation on Intracranial Progression-Free Survival of Non-Small Cell Lung Cancer Patients with Brain Metastasis Underwent Gamma Knife Radiosurgery
Seung-Hyeon Yang, Hae Yu Kim, Sun-il Lee, Seong Jin Jin
Brain Tumor Research and Treatment.2020; 8(2): 103.     CrossRef
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review
Liliana Belgioia, Isacco Desideri, Angelo Errico, Ciro Franzese, Antonino Daidone, Lorenza Marino, Michele Fiore, Paolo Borghetti, Daniela Greto, Alba Fiorentino
Critical Reviews in Oncology/Hematology.2019; 133: 163.     CrossRef
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
Wen-Chi Yang, Furen Xiao, Jin-Yuan Shih, Chao-Chi Ho, Ya-Fang Chen, Ham-Min Tseng, Kuan-Yu Chen, Wei-Yu Liao, Chong-Jen Yu, James Chih-Hsin Yang, Sung-Hsin Kuo, Jason Chia-Hsien Cheng, Pan-Chyr Yang, Feng-Ming Hsu
Radiotherapy and Oncology.2018; 126(2): 368.     CrossRef
Efficacy and Safety of Radiotherapy Plus EGFR-TKIs in NSCLC Patients with Brain Metastases: A Meta-Analysis of Published Data
Xueyan Wang, Ye Xu, Weiqing Tang, Lingxiang Liu
Translational Oncology.2018; 11(5): 1119.     CrossRef
Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy
A.V. Tallet, F. Dhermain, E. Le Rhun, G. Noël, Y.M. Kirova
Annals of Oncology.2017; 28(12): 2962.     CrossRef
SBRT for oligoprogressive oncogene addicted NSCLC
L. Basler, S.G.C. Kroeze, M. Guckenberger
Lung Cancer.2017; 106: 50.     CrossRef
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review
Stephanie G.C. Kroeze, Corinna Fritz, Morten Hoyer, Simon S. Lo, Umberto Ricardi, Arjun Sahgal, Rolf Stahel, Roger Stupp, Matthias Guckenberger
Cancer Treatment Reviews.2017; 53: 25.     CrossRef
Surgery in Oligometastatic NSCLC Patients in the Targeted Therapy Era
Qi Zhang, Yi-Long Wu
Lung Cancer Management.2016; 5(3): 141.     CrossRef